PMID: 2120029Jul 1, 1990Paper

Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine

L'Encéphale
D ServantP J Parquet

Abstract

In a sample of 35 patients with a diagnosis of panic disorder or agoraphobia with panic attacks according DSM III criteria, the authors found 8 patients (23%) with obsessive compulsive symptoms. This subgroup and 7 patients without obsessive compulsive symptoms were treated with fluvoxamine, a selective serotonin uptake inhibitor in an 8 weeks open study (2 weeks wash out, 6 weeks treatment). At the end of the study, a dramatic reduction of anxiety was found in different rating scales. Ten patients improved and no panic attack was noted: 7 in the group with obsessive compulsive symptoms (N = 8) and 3 in the group without obsessive compulsive symptoms (N = 7). Interest of fluvoxamine in panic patients with obsessive compulsive symptoms who do not respond to common antipanic medication is suggested. Controlled studies are necessary to confirm these first results.

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.